#HPV

Teens can receive the cancer-preventing HPV vaccine at the same time as their COVID-19 vaccine.

Women living with HIV in the United States have a greater likelihood of developing cervical cancer than HIV-negative women.

The vaccine protects against nine types of human papillomavirus, including those that cause cervical and anal cancer.

Study suggests HIV-positive women could start cervical cancer screening at age 21.

The National Comprehensive Cancer Network publishes a new guide that includes updated patient guidelines for colon and rectal cancers.

The early cancer is detected, the easier it is to treat.

However, other malignancies caused by human papillomavirus, including anal and oral cancers, are on the rise.

While researchers try to figure out whether treating early anal tissue changes can prevent cancer, some are investigating treatments.

A recent study analyzed immune responses to the HPV vaccine among HIV-positive youths 7 to 20 years old.

Compared with unvaccinated women, the risk among women vaccinated before age 17 dropped by almost 90%.

Human papillomavirus, which causes genital warts and various cancers, is preventable with a vaccine.

A rundown of POZ’s reporting on the 2020 Conference on Retroviruses and Opportunistic Infections

Oral STIs include chlamydia, gonorrhea, herpes simplex and human papillomavirus.

Study finds that routine screening reduces anal cancer rate among people with HIV.

This finding may reflect higher rates of sexually transmitted infections such as HPV and hep B as well as lifestyle factors.

Keytruda may prolong survival compared with standard therapy.